PACB 1.8 (+1.69%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

53 / 58

Performance 5 years

43 / 58

Performance 10 years

40 / 58

Linearity 3 years

46 / 58

Linearity 5 years

15 / 58

Linearity 10 years

12 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Performance 5 years - PACB ranking 43 / 58

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
350.15
2. RadNet RDNT
343.29
3. Natera NTRA
331.97
4. Lantheus Holdings LNTH
320.01
5. Meridian Bioscience VIVO
118.46
6. Danaher DHR
85.26
7. Twist Bioscience TWST
84.01
8. Mettler-Toledo MTD
71.68
9. Waters WAT
71.32
10. Agilent Technologies A
70.26
11. Thermo Fisher Scientific TMO
67.67
12. Laboratory Corp of America Holdings LH
64.1
13. DarioHealth DRIO
61.4
14. IDEXX Laboratories IDXX
59.94
15. Quest Diagnostics DGX
55.56
16. PerkinElmer PKI
48.44
17. IQVIA Holdings IQV
40.06
18. Charles River Laboratories CRL
39.05
19. Icon ICLR
37.6
20. Fulgent Genetics FLGT
35.17
21. DexCom DXCM
33.95
22. CareDx CDNA
16.69
23. Ortho Clinical Diagnostics Holdings OCDX
13.74
24. Heska HSKA
12.14
25. Co-Diagnostics CODX
11.58
26. Qiagen QGEN
2.99
27. Inotiv NOTV
-10.5
28. Anixa Biosciences ANIX
-13.07
29. Syneos Health SYNH
-16.98
30. Bioventus BVS
-23.77
31. Olink Holding OLK
-26.82
32. Exact Sciences EXAS
-36.87
33. NeoGenomics NEO
-37.36
34. Myriad Genetics MYGN
-39.66
35. Sotera Health SHC
-54.04
36. Illumina ILMN
-54.1
37. Neogen NEOG
-54.47
38. Interpace Biosciences IDXG
-57.46
39. Sera Prognostics SERA
-59.29
40. Guardant Health GH
-60.61
41. Personalis PSNL
-61.72
42. Enzo Biochem ENZ
-65.26
43. Pacific Biosciences of California PACB
-65.7
44. National Research NRC
-69.21
45. Trinity Biotech TRIB
-70.45
46. Psychemedics PMD
-75.37
47. Exagen XGN
-79.19
48. MaxCyte MXCT
-79.69
49. Precipio PRPO
-85.15
50. bioAffinity Technologies BIAF
-85.24
51. MDxHealth MDXH
-85.93
52. Global Cord Blood CO
-86.47
53. Biodesix BDSX
-91.17
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.31
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.